Jazz Pharmaceuticals PLC (JAZZ)

Add to Watchlists
Create an Alert
134.92 +1.79  +1.34% NASDAQ Jul 15, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2019 16:30 EDT Misc Jazz Pharmaceuticals PLC Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Jazz Pharmaceuticals PLC Second Quarter Earnings in 2019 Release
05/07/2019 16:30 EDT Misc Jazz Pharmaceuticals PLC First Quarter Earnings Conference Call in 2019
05/07/2019 Earnings Jazz Pharmaceuticals PLC First Quarter Earnings in 2019 Release
02/26/2019 16:30 EST Misc Jazz Pharmaceuticals PLC Fourth Quarter Earnings Conference Call in 2018
02/26/2019 Earnings Jazz Pharmaceuticals PLC Fourth Quarter Earnings in 2018 Release
02/26/2019 Misc Jazz Pharmaceuticals PLC Annual Report in 2018
11/06/2018 16:30 EST Misc Jazz Pharmaceuticals PLC Third Quarter Earnings Conference Call in 2018
11/06/2018 Earnings Jazz Pharmaceuticals PLC Third Quarter Earnings in 2018 Release
08/07/2018 16:30 EDT Misc Jazz Pharmaceuticals PLC Second Quarter Earnings Conference Call in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.jazzpharmaceuticals.com
  • Investor Relations URL: http://investor.jazzpharma.com/phoenix.zhtml?c=210227&p=irol-irhome
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: Aug. 07, 2019
  • Last Earnings Release: May. 07, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Jazz Pharmaceuticals is an Ireland-domiciled specialty pharmaceutical firm focused primarily on treatments for orphan drug indications. Jazz's product portfolio includes lead drug Xyrem for narcolepsy, Erwinaze for acute lymphoblastic leukemia, Defitelio for severe veno-occlusive disease, and Vyxeos for acute myeloid leukemia.

Top Fund Holders

Symbol Name Weighting
PYSMX Putnam Equity Spectrum M 12.55%
PVSMX Putnam Capital Spectrum M 12.51%
XPH SPDR® S&P Pharmaceuticals ETF 4.43%
PPH VanEck Vectors Pharmaceutical ETF 4.08%
IHE iShares US Pharmaceuticals ETF 3.40%
PJP Invesco Dynamic Pharmaceuticals ETF 2.84%
RBF1092 RBC U.S. Mid-Cap Value Equity Fund D 2.51%
FRBRX Franklin Biotechnology Discovery R6 2.17%
FZAKX Fidelity Advisor® Leveraged Co Stk Z 1.63%
IBB iShares Nasdaq Biotechnology ETF 1.03%
FZAMX Fidelity Advisor® Mid Cap II Z 1.01%
HQL Tekla Life Sciences Investors 0.78%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("JAZZ","name")
  • Description: =YCI("JAZZ","description")
  • Sector: =YCI("JAZZ","sector")
  • Industry: =YCI("JAZZ","industry")
  • Est. Current Fiscal Year End: =YCI("JAZZ","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.